Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Heat Shock Factor 1 Reprograms the DLBCL Microenvironment to Evade Immune Surveillance and Support Tumor Growth

Jude M Phillip, DPhil, Maria Nieves Calvo Vidal, PhD, Maria Victoria Revuelta, PhD, Nahuel Zamponi, PhD, Stephen Sloan, Benet Pera Gresely, PhD, Tharu Fernando, PhD, Wayne Tam, MD PhD, Giorgio Inghirami, MD, Lawrence Bonassar, PhD, Ari M. Melnick, MD, Leandro Cerchietti, MD

Blood (2018) 132 (Supplement 1): 2854.

https://doi.org/10.1182/blood-2018-99-117774

Published: 2018

Journal Articles

Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells

Florencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, Shao Ning Yang, Helena Andrea Sterle, Marcela Bolontrade, Mariana Amorós, Blanca Isse, Ricardo Norberto Farías, Haelee Ahn, Ye F. Tian, Fabrizio Tabbò, Ankur Singh, Giorgio Inghirami, Leandro Cerchietti, Graciela Alicia Cremaschi

Blood (2015) 125 (5): 841–851.

https://doi.org/10.1182/blood-2014-07-587337

Published: 2015

Includes: Supplemental data

Journal Articles

Integrin αvβ3 Transduces Survival and Angiogenic Signals to T Cell Lymphomas and Is a Therapeutic Target

Maria Florencia Cayrol, PhDstudent, Maria Celeste Diaz Flaque, PhD, Tharu Fernando, PhDstudent, Shao Ning Yang, Marcela Bolontrade, PhD, Mariana Amoros, Ricardo Farias, PhD, Giorgio Inghirami, MD, Graciela Cremaschi, PhD, Leandro Cerchietti, MD

Blood (2014) 124 (21): 510.

https://doi.org/10.1182/blood.V124.21.510.510

Published: 2014

Journal Articles

Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs

Maria Florencia Cayrol, PhD student, Tharu Fernando, PhD student, María Celeste Díaz Flaqué, Shao Ning Yang, Ricardo Farias, Graciela Cremaschi, Leandro Cerchietti, MD

Blood (2013) 122 (21): 3810.

https://doi.org/10.1182/blood.V122.21.3810.3810

Published: 2013

Journal Articles

The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)

Biljana Culjkovic, PhD, Tharu Fernando, PhD student, ShaoNing Yang, MS, Ari M. Melnick, MD, Katherine LB Borden, PhD, Leandro Cerchietti, MD

Blood (2013) 122 (21): 3785.

https://doi.org/10.1182/blood.V122.21.3785.3785

Published: 2013

NARROW

Heat Shock Factor 1 Reprograms the DLBCL Microenvironment to Evade Immune Surveillance and Support Tumor Growth

Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells

Integrin αvβ3 Transduces Survival and Angiogenic Signals to T Cell Lymphomas and Is a Therapeutic Target

Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs

The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)

Email alerts

ASH Publications

American Society of Hematology

Heat Shock Factor 1 Reprograms the DLBCL Microenvironment to Evade Immune Surveillance and Support Tumor Growth

Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells

Integrin αvβ3 Transduces Survival and Angiogenic Signals to T Cell Lymphomas and Is a Therapeutic Target

Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs

The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only